Interact to see
Advertisement
Advertisement
NAD vs NUV
NAD vs NUV Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
NAD vs. NUV commentary
Jul 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAD is a Hold and NUV is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
NAD has more net assets: 2.67B vs. NUV (1.83B). NUV has a higher annual dividend yield than NAD: NUV (2.068) vs NAD (-0.297). NAD was incepted earlier than NUV: NAD (26 years) vs NUV (38 years). NUV (0.47) has a lower expense ratio than NAD (1.41). NUV has a higher turnover NAD (18.00) vs NAD (18.00).
| NAD | NUV | NAD / NUV | |
| Gain YTD | -0.297 | 2.068 | -14% |
| Net Assets | 2.67B | 1.83B | 146% |
| Total Expense Ratio | 1.41 | 0.47 | 300% |
| Turnover | 18.00 | 21.00 | 86% |
| Yield | 5.32 | 4.22 | 126% |
| Fund Existence | 26 years | 38 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| NAD | NUV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 44% | 3 days ago 70% |
| Stochastic ODDS (%) | 3 days ago 80% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 59% | 3 days ago 69% |
| MACD ODDS (%) | 3 days ago 63% | 3 days ago 76% |
| TrendWeek ODDS (%) | 3 days ago 64% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 77% | 3 days ago 74% |
| Advances ODDS (%) | 13 days ago 77% | 3 days ago 76% |
| Declines ODDS (%) | 4 days ago 72% | 5 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 67% | 3 days ago 70% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVIX | 10.10 | 0.06 | +0.60% |
| American Century Small Cap Value Inv | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GCLLX | 17.21 | 0.06 | +0.35% |
| Goldman Sachs Enhanced U.S. Equity C | |||
| VECRX | 22.33 | 0.07 | +0.31% |
| Virtus KAR Equity Income R6 | |||
| FBTTX | 25.58 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||